Exabis Library
Welcome to the e-CCO Library!
Only medical treatment can solve the problem!
 2019
 8th S-ECCO IBD Masterclass
 Tuesday, 28 May 2019, 3:32 PM
 1
OP001: Whole genome sequencing and imputation in Inflammatory Bowel Disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insights
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 11:02 AM by Vesna Babaja
 1
OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s Disease cohort shows a quiescent disease course for a substantial proportion of the population
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1
OP002: Epigenetic biomarkers to detect UC associated neoplasia: Results from phase I of the ENDCAP-C study
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 1:35 PM by ECCO Administrator
 1
OP003: Increased risk of acute arterial events in young patients with severely active Inflammatory Bowel Disease: A nationwide French cohort study
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 1:43 PM by ECCO Administrator
 1
OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomics
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn‘s Disease
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 1:48 PM by ECCO Administrator
 1
OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in Ulcerative Colitis
 2018
 ECCO'18 Vienna
 Friday, 9 November 2018, 10:21 AM by Lindley Fritze
OP005: The PROSIT cohort of infliximab biosimilar in IBD: A prolonged follow-up on the efficacy and safety across Italy
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 1:53 PM by ECCO Administrator
 1
OP006: Apremilast for active Ulcerative Colitis: A phase 2, randomised, double-blind, placebo-controlled induction study
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1
OP006: Correlation of durability of response, serum trough concentrations and outcome parameters: Long-term follow-up of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trial
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 1:55 PM by ECCO Administrator
 1
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 2:21 PM by ECCO Administrator
 1
OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative Colitis
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1
OP008: An innovative treatment for refractory perianal fistulas in Crohn’s Disease: Local micro reinjection of autologous fat and adipose derived stromal vascular fraction (ClinicalTrials. gov NCT02520843, Eudract: 2013-002602-31)
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 2:24 PM by ECCO Administrator
 1
OP009: A combination of clinical, serological and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study.
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 2:43 PM by ECCO Administrator
 1
OP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
 2017
 ECCO'17 Barcelona
 Wednesday, 15 March 2017, 2:45 PM by ECCO Administrator
 1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1
OP011: Integration of whole exome sequencing and RNA sequencing of intestinal biopsies in Inflammatory Bowel Disease identifies inflammation dependent effects
 2018
 ECCO'18 Vienna
 Friday, 23 March 2018, 12:23 PM
 1